The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Buy BPC 157 Peptide 99%+ Pure BPC 157 for Research Empower 503B Outsourcing Facility Serving Retail Pharmacies What is a 503B outsourcing facility, and why are so many of them uninspected by FDA? Partnership for Safe Medicines Pharmacy Purchasing & Products Magazine Why the FDA Is Paying More Attention to 503A & 503B Pharmacies If you've been watching the compounding space, especially around GLP 1s and peptides, you've probably noticed something. The FDA is paying